Louisbourg Investments’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$616K Hold
1,700
0.11% 105
2026
Q1
$598K Hold
1,700
0.11% 108
2025
Q4
$556K Hold
1,700
0.11% 107
2025
Q3
$480K Hold
1,700
0.1% 103
2025
Q2
$475K Hold
1,700
0.11% 104
2025
Q1
$530K Hold
1,700
0.14% 97
2024
Q4
$443K Hold
1,700
0.12% 100
2024
Q3
$548K Hold
1,700
0.14% 94
2024
Q2
$531K Sell
1,700
-800
-32% -$235K 0.15% 91
2024
Q1
$711K Hold
2,500
0.2% 82
2023
Q4
$720K Buy
+2,500
New +$681K 0.22% 83

Other funds holding AMGN

Louisbourg Investments's AMGN Position: Q2 2026 in Review

Louisbourg Investments held its Amgen (AMGN) position steady in Q2 2026 at 1,700 shares worth $616K. The position accounts for 0.11% of the portfolio, ranked #105.

Louisbourg Investments first reported a position in AMGN in Q4 2023 and has held it in 11 quarters since. The position peaked at $720K in Q4 2023. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Louisbourg Investments held 1,700 shares of Amgen worth $616K as of Q2 2026.
  • Louisbourg Investments left its Amgen share count unchanged in Q2 2026.
  • Amgen made up 0.11% of Louisbourg Investments's portfolio in Q2 2026, its #105 holding.
  • Louisbourg Investments first reported a position in Amgen in Q4 2023 and has held it in 11 quarters since.
  • Louisbourg Investments's Amgen position peaked at $720K in Q4 2023.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Louisbourg Investments's 13F filing for Q2 2026, filed 23 Jul 2026.